Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.74−0.08 (-9.49%)
Close on Nov 17, 2026Market cap $68.60MP/E –Yield –
Anavex Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Anavex Life Sciences's enterprise value was -$20.07M on Nov 11, 2026, against $229.36M a year earlier. Over the last 5 years it ranged from -$20.07M to $1.16B, with a median of $508.48M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$20.07M | -109.7% |
| 2025 | Dec 31, 2025 | $205.96M | -73.5% |
| 2024 | Dec 31, 2024 | $778.52M | +27.0% |
| 2023 | Dec 29, 2023 | $613.02M | +7.1% |
| 2022 | Dec 30, 2022 | $572.59M | -50.8% |
| 2021 | Dec 31, 2021 | $1.16B | +280.8% |
| 2020 | Dec 31, 2020 | $305.80M | +167.8% |
| 2019 | Dec 31, 2019 | $114.18M | +134.3% |
| 2018 | Dec 31, 2018 | $48.73M | -56.5% |
| 2017 | Dec 29, 2017 | $112.08M | -16.4% |
| 2016 | Dec 30, 2016 | $134.04M | -17.9% |
| 2015 | Dec 31, 2015 | $163.20M | +2097.7% |
| 2014 | Dec 31, 2014 | $7.43M | -17.2% |
| 2013 | Dec 31, 2013 | $8.96M | -62.5% |
| 2012 | Dec 31, 2012 | $23.88M | -26.0% |
| 2011 | Dec 30, 2011 | $32.28M | -62.3% |
| 2010 | Dec 31, 2010 | $85.57M | – |
See a number that looks wrong?